Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that finasteride can reduce nandrolone detection in doping tests, suggesting frequent testing and setting metabolite level thresholds for detection.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Silver can help prevent and treat infections but its effectiveness varies and should be weighed against costs and side effects.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Testosterone's muscle-building effects do not require its conversion to DHT.

Nearly half of the classification tools in the National Institute of Health and Clinical Excellence's Clinical Knowledge Summaries might not effectively guide management for general practitioners.

Child abuse is linked to higher BMI, but not because of hair cortisol or cortisone levels.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Urinary PSA could be an early marker for enlarged prostate.

Baldness score can't be used to predict prostate size.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Men with better urinary symptoms have a lower risk of death.

Finasteride improves urinary function in men for 2 years.